NB1011
Term · Oncology and biomedicine · MLC-T-ONC-005696
A substance that is being studied for its ability to make cancer cells respond to drugs to which they have become resistant. It is a type of nucleoside analog.
| Identifier | MLC-T-ONC-005696 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005696",
"term": "NB1011",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied for its ability to make cancer cells respond to drugs to which they have become resistant. It is a type of nucleoside analog.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/nb1011/"
}
Record 11,637 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.